Nadim Ahmed

Insider Reports History

Entity
Individual
Location
C/O Celgene Corporation, 86 Morris Avenue, Summit, NJ
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nadim Ahmed:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. President and CEO, Director Common Stock 272K $4.39M $16.18 Feb 22, 2024 Direct
Cullinan Oncology, Inc. President and CEO, Director Stock Option (Right to Buy) 320K Feb 22, 2024 Direct

Insider Reports Filed by Nadim Ahmed

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Oncology, Inc. Feb 22, 2024 2 $0 4 Feb 23, 2024 President and CEO, Director
CGEM Cullinan Oncology, Inc. Dec 26, 2023 1 -$39.5K 4 Dec 27, 2023 President and CEO, Director
CGEM Cullinan Oncology, Inc. Jun 28, 2023 1 -$8.65K 4 Jun 29, 2023 President and CEO, Director
CGEM Cullinan Oncology, Inc. May 23, 2023 1 -$6.47K 4 May 24, 2023 President and CEO, Director
CGEM Cullinan Oncology, Inc. Apr 25, 2023 1 -$7.58K 4 Apr 26, 2023 President and CEO, Director
CGEM Cullinan Oncology, Inc. Mar 23, 2023 1 -$7.42K 4 Mar 27, 2023 President and CEO, Director
CGEM Cullinan Oncology, Inc. Feb 22, 2023 2 $0 4 Feb 23, 2023 President and CEO, Director
CGEM Cullinan Oncology, Inc. Jun 30, 2022 1 $17.7K 4 Jul 5, 2022 President and CEO, Director
CGEM Cullinan Oncology, Inc. Jun 6, 2022 1 $100K 4 Jun 7, 2022 President and CEO, Director
CGEM Cullinan Oncology, Inc. Mar 5, 2022 1 $0 4 Mar 7, 2022 President and CEO, Director
CGEM Cullinan Oncology, Inc. Oct 18, 2021 1 $0 4 Oct 20, 2021 President and CEO, Director
CGEM Cullinan Oncology, Inc. Oct 18, 2021 0 $0 3 Oct 20, 2021 President and CEO, Director